Products
Platform
Research
Market
Learn
Partner
Support
IPO

V

Valiant Laboratories IPO

₹14,700 / 105 shares

Issue Date

--

Price Range

₹140

Lot Size

105

IPO Size

₹152.46 Cr

Valiant Laboratories IPO Listing Details

Listing On

6 Oct'23

Issue Price

--

Listed Price

₹ 162.15

Retail Gain/Listing Gain

15.82%

Schedule of Valiant Laboratories IPO

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

06/10/2023

Valiant Laboratories Limited is an active pharmaceutical ingredient (API)/bulk drug manufacturing company, with a focus on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations.

India is the largest provider of generic drugs, globally contributing to approximately 20% of global supply by volume of generic drugs. The overall API industry in India grew from Rs. 781 billion in fiscal 2017 to Rs. 1,179 billion in fiscal 2022, registering a CAGR of 8.5% in rupee terms. Going forward, the API industry is expected to grow at a rate of 9-11% between fiscal 2022 and 2027, largely driven by the increase in API exports. More specifically, the paracetamol API industry (domestic + exports) grew from Rs. 22 billion in fiscal 2017 to Rs. 39 billion in fiscal 2023.

Read More
  • Any changes to the paracetamol API industry or the company’s product demand will adversely affect revenues, financials and profitability.
  • The company is dependent on a single manufacturing facility.
  • The company must always be subject to strict quality requirements, regular inspections and audits.
  • Diversification into new chemistries.
  • Increase penetration into international markets including regulated markets.
  • Improve operational efficiencies through backward integration of the proposed facility.
Loading chart...
Here's a video playlist to help you invest in the upcoming Valiant Laboratories Limited IPO
How to apply for IPO through ASBA

Kotak Securities

00m 59s

How to apply for an IPO using UPI
Kotak Securities 01m 19s
Apply for Valiant Laboratories IPO